the package insert of the medicine Sintozima. Therapeutic class of Antifermentativos, Pancreatic Enzymesand Est. of Motil. and Secretion of Gastr.. Active principles Pancreatin, Bromelain, Dimethicone,Metoclopramide, Acid Deidrocolico and Cellulase.
SINTOZIMA® is indicated in disorders of the digestive tract resulting disability
the enzyme or changes of motility, meteorism, flatulence, feeling of fullness stomach and in the dispepsias of varied origins.
When should I not use?
In cases of hypersensitivity to any of the components of the formulation, in patients with biliary obstruction mechanical, hepatitis severe, pheochromocytoma or parkinsonism and epileptic patients in treatment. Not indicated in the syndromes obstructive bowel and constipation.
How to use?
One to two tablets, during or shortly after the main meals, and should the doctor prescribe the appropriate dose for use by children, the elderly and malnourished patients.
What are the evils that can cause me?
SINTOZIMA can cause constipation, diarrhea, somnolence (4%), lassitude (9,8%),
intestinal disorders (1,2%), nausea and vomiting.
Rarely can occur extrapyramidal reactions (1%). Especially in children, may exceptionally occur galactorrhea, dizziness (up 0.8%), agitation and anxiety, periorbital edema and tongue, skin rashes and pain in the oral and perianal.
In elderly patients can cause dyskinesia and, in the malnourished, can occur extrapyramidal effects.
Warnings and Precautions
what should I know before using?
Due to the presence of metoclopramide in the formulation, the dosage of use for children and the elderly should be appropriate to the physician’s discretion. In the case of the indication during the pregnancy, making careful assessment of risks and benefits.
In diabetic patients should consider the sugar content of the tablets (0,23 g/drágea).
what to do if someone use a larger amount than is recommended?
In case of ingestion exaggerated, one should proceed to gastric emptying by rinsing or vacuuming. The extrapyramidal reactions may be controlled with the use of antiparkinsonianos. The dyskinesia that can occur is self-limited, disappearing in 24 hours, which may be controlled with anticholinergics and antiparkinsonianos.